Skip to content

Clinical trials

Essential Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Clear all

467 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20036
20049
20059
200615
200724
200819
200918
201025
201124
201218
201321
201420
201522
201610
201710
201822
201919
202012
202116
202227
202329
202436
202523
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed315
Unknown status81
Recruiting30
Not yet recruiting21
Active, not recruiting9
Terminated7
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boryung Pharmaceutical Co., Ltd43
Chong Kun Dang Pharmaceutical18
Novartis Pharmaceuticals15
Takeda14
Novartis12
Bayer9
Daiichi Sankyo9
Addpharma Inc.8
AstraZeneca6
Regional Hospital Holstebro6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension467
Hypertension171
Cardiovascular Diseases27
Vascular Diseases14
Diabetes Mellitus, Type 213
Metabolic Syndrome8
Hyperaldosteronism7
Heart Failure6
Hyperlipidemias6
Obesity6

Trials

Showing 51 to 75 of 467. Each trial links to its page on Pharma Observatory.

367 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.